https://www.selleckchem.com/products/Cediranib.html Thrombectomy increases the survival rate of acute ischemic stroke patients corresponding to large vessel occlusion. This study aimed to determine clinical predictors for good outcomes in patients subjected to tissue window guided thrombectomy. This study was performed at the stroke center of the First Affiliated Hospital of SooChow University. Baseline characteristics and outcomes were retrospectively collected, 90 days after endovascular thrombectomy. Collection was done within 6-24 hours after a patient was last seen in good condition. Binary logistic regression wasused to establish the clinical predictors for functional independence. Receiver operator characteristic curve analysis was performed to determine cutoff values for outcome predictors. P value <0.05 was considered to be statistically significant. Forty-seven patients were enrolled in this study. Among them, 13 (27.7%) had last presenting stroke, 24 (51.1%) had wake-up stroke, and 10 (21.3%) had daytime unknown stroke onset. The median iniwindow based thrombectomy. The best management of asymptomatic moyamoya disease (MMD) remains controversial. In this study, the authors aimed to explore an experience for treatment modality for asymptomatic MMD. The authors retrospectively reviewed a total of 23 patients (age range 30-58 years) with asymptomatic MMD during the past 5 years at their institutions. The patients were divided into 2 groups The surgical group included 11 patients, and the conservative group included 12 patients. The demographic, radiologic, and clinical findings of the patients were evaluated. At follow-up over 13-65 months, the future clinical and radiologic progression events were evaluated. During the follow-up period, 3 patients suffered from future clinical progression events in the conservative group 1 experienced stroke, and 2 experienced transient ischemic attack. Among the patients in the surgical group, only 1 experienced transient